Literature DB >> 26186466

Acute Phase Proteins in Cerebrospinal Fluid from Dogs with Naturally-Occurring Spinal Cord Injury.

Kimberly M Anderson1, C Jane Welsh2, Colin Young2, Gwendolyn J Levine3, Sharon C Kerwin1, C Elizabeth Boudreau1, Ismael Reyes2, Armando Mondragon2, John F Griffin4, Noah D Cohen4, Jonathan M Levine1.   

Abstract

Spinal cord injury (SCI) affects thousands of people each year and there are no treatments that dramatically improve clinical outcome. Canine intervertebral disc herniation is a naturally-occurring SCI that has similarities to human injury and can be used as a translational model for evaluating therapeutic interventions. Here, we characterized cerebrospinal fluid (CSF) acute phase proteins (APPs) that have altered expression across a spectrum of neurological disorders, using this canine model system. The concentrations of C-reactive protein (CRP), haptoglobin (Hp), alpha-1-glycoprotein, and serum amyloid A were determined in the CSF of 42 acutely injured dogs, compared with 21 healthy control dogs. Concentrations of APPs also were examined with respect to initial injury severity and motor outcome 42 d post-injury. Hp concentration was significantly higher (p<0.0001) in the CSF of affected dogs, compared with healthy control dogs. Additionally, the concentrations of CRP and Hp were significantly (p=0.0001 and p=0.0079, respectively) and positively associated with CSF total protein concentration. The concentrations of CRP and Hp were significantly higher (p=0.0071 and p=0.0197, respectively) in dogs with severe injury, compared with those with mild-to-moderate SCI, but there was no significant correlation between assessed CSF APP concentrations and 42 d motor outcome. This study demonstrated that CSF APPs were dysregulated in dogs with naturally-occurring SCI and could be used as markers for SCI severity. As Hp was increased following severe SCI and is neuroprotective across a number of model systems, it may represent a viable therapeutic target.

Entities:  

Keywords:  biomarkers; canine; neurotrauma; secondary injury

Mesh:

Substances:

Year:  2015        PMID: 26186466      PMCID: PMC4638197          DOI: 10.1089/neu.2015.3895

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  46 in total

1.  Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.

Authors:  Honghao Wang; Kai Wang; Conghui Wang; Xiaonan Zhong; Wei Qiu; Xueqiang Hu
Journal:  Mult Scler       Date:  2012-09-25       Impact factor: 6.312

2.  Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment.

Authors:  Kevin D Beck; Hal X Nguyen; Manuel D Galvan; Desirée L Salazar; Trent M Woodruff; Aileen J Anderson
Journal:  Brain       Date:  2010-01-19       Impact factor: 13.501

Review 3.  Incidence, prevalence, costs, and impact on disability of common conditions requiring rehabilitation in the United States: stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, osteoarthritis, rheumatoid arthritis, limb loss, and back pain.

Authors:  Vincent Y Ma; Leighton Chan; Kadir J Carruthers
Journal:  Arch Phys Med Rehabil       Date:  2014-01-21       Impact factor: 3.966

4.  The role of acute phase proteins in diagnosis and management of steroid-responsive meningitis arteritis in dogs.

Authors:  M Lowrie; J Penderis; P D Eckersall; M McLaughlin; D Mellor; T J Anderson
Journal:  Vet J       Date:  2008-06-30       Impact factor: 2.688

5.  Proteome study of human cerebrospinal fluid following traumatic brain injury indicates fibrin(ogen) degradation products as trauma-associated markers.

Authors:  Antonio Conti; Yovan Sanchez-Ruiz; Angela Bachi; Luigi Beretta; Elisabetta Grandi; Massimiliano Beltramo; Massimo Alessio
Journal:  J Neurotrauma       Date:  2004-07       Impact factor: 5.269

6.  Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease.

Authors:  Sang Min Jung; Kibeom Lee; Joung Wook Lee; Hong Namkoong; Hyun Kee Kim; Sanghee Kim; Hae Ri Na; Seon-Ah Ha; Jae-Ryong Kim; Jesang Ko; Jin Woo Kim
Journal:  Neurosci Lett       Date:  2008-03-18       Impact factor: 3.046

7.  Recovery of locomotion after chronic spinalization in the adult cat.

Authors:  H Barbeau; S Rossignol
Journal:  Brain Res       Date:  1987-05-26       Impact factor: 3.252

8.  Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure.

Authors:  Georgene Hergenroeder; John B Redell; Anthony N Moore; William P Dubinsky; Robert T Funk; John Crommett; Guy L Clifton; Robert Levine; Alex Valadka; Pramod K Dash
Journal:  J Neurotrauma       Date:  2008-02       Impact factor: 5.269

9.  Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease.

Authors:  Mark Yarchoan; Natalia Louneva; Sharon X Xie; Frank J Swenson; William Hu; Holly Soares; John Q Trojanowski; Virginia M-Y Lee; Mitchel A Kling; Leslie M Shaw; Alice Chen-Plotkin; David A Wolk; Steven E Arnold
Journal:  J Neurol Sci       Date:  2013-08-23       Impact factor: 3.181

10.  Efficacy of a metalloproteinase inhibitor in spinal cord injured dogs.

Authors:  Jonathan M Levine; Noah D Cohen; Michael Heller; Virginia R Fajt; Gwendolyn J Levine; Sharon C Kerwin; Alpa A Trivedi; Thomas M Fandel; Zena Werb; Augusta Modestino; Linda J Noble-Haeusslein
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

View more
  5 in total

1.  Rational design and characterization of a lateral flow assay for canine C-reactive protein in wound exudate.

Authors:  Corey Downs; Milan Milovancev; Elain Fu
Journal:  Talanta       Date:  2020-07-07       Impact factor: 6.057

2.  Utility of C-reactive protein and serum amyloid A in the diagnosis of equine protozoal myeloencephalitis.

Authors:  Neil S Mittelman; Darko Stefanovski; Amy L Johnson
Journal:  J Vet Intern Med       Date:  2018-09-14       Impact factor: 3.333

3.  Identification of novel biomarkers for neonatal hypoxic-ischemic encephalopathy using iTRAQ.

Authors:  Yuanyuan Zhu; Yajing Yun; Meifang Jin; Gen Li; Hong Li; Po Miao; Xin Ding; Xing Feng; Lixiao Xu; Bin Sun
Journal:  Ital J Pediatr       Date:  2020-05-24       Impact factor: 2.638

4.  Arachidonic acid pathway alterations in cerebrospinal fluid of dogs with naturally occurring spinal cord injury.

Authors:  Rae L Russell; Jonathan M Levine; Nick D Jeffery; Colin Young; Armando Mondragon; Bryan Lee; C Elizabeth Boudreau; C Jane Welsh; Gwendolyn J Levine
Journal:  BMC Neurosci       Date:  2016-06-10       Impact factor: 3.288

Review 5.  Current Insights Into the Pathology of Canine Intervertebral Disc Extrusion-Induced Spinal Cord Injury.

Authors:  Ingo Spitzbarth; Sarah A Moore; Veronika M Stein; Jonathan M Levine; Bianca Kühl; Ingo Gerhauser; Wolfgang Baumgärtner
Journal:  Front Vet Sci       Date:  2020-10-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.